Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024

2004年至2024年河南省接受抗逆转录病毒治疗的艾滋病毒感染者的生存分析

阅读:2

Abstract

There is a significant gap in data regarding the survival time and the factors influencing the survival of people living with HIV (PLWH) undergoing antiretroviral therapy (ART) in Henan Province, a region severely impacted by the AIDS epidemic.Investigating survival and influencing factors after ART can provide valuable insights to enhance patient management strategies and improve the prognosis for PLWH.This retrospective cohort study compiled case data and follow-up records of PLWH receiving ART at the Infectious Disease Hospital of Henan Province between 2004 and 2024. Survival curves were generated using the Kaplan-Meier method, and both univariate and multivariate Cox proportional hazards models were employed to identify factors influencing survival outcomes. Among the 4,307 study participants, a total of 251 (5.83%) patients died. The overall cumulative survival rate to the observation endpoint was 80%. The multifactorial Cox proportional risk regression modeling analysis of the primary outcomes showed that patients aged > 60 years at diagnosis of HIV/AIDS (HR = 4.706, 95% CI: 2.175 ~ 10.180), transmission route of heterosexual (HR = 1.403, 95% CI: 1.021 ~ 1.928) and blood transmission (HR = 1.855, 95% CI:1.206 ~ 2.855), patients with CD4(+) T cell count < 200cells/µL (HR = 1.636,95% CI: 1.136 ~ 2.354) had a higher risk of death. Our findings highlight the importance of targeted ART management for high-risk populations, such as older individuals, heterosexual or blood-borne transmission and those with low CD4(+) T cell count, to further improve survival outcomes and optimize HIV/AIDS treatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。